Critical flicker frequency and continuous reaction times for the diagnosis of minimal hepatic encephalopathy. A comparative study of 154 patients with liver disease

Metabolic Brain Disease

Volumn 26, Issue 2, 2011, Pages 135-139

  Lauridsen, Mette Munk ^a,b   Jepsen, Peter ^a   Vilstrup, Hendrik ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b ESBJERG HOSPITAL   (Denmark)

Author keywords

Continuous reaction time; Critical flicker frequency; Minimal hepatic encephalopathy; Subclinical hepatic encephalopathy

Indexed keywords

AMMONIA; GALACTOSE;

ADULT; AGED; AMMONIA BLOOD LEVEL; ARTICLE; ASTROCYTE; CELL METABOLISM; COMPARATIVE STUDY; CONTINUOUS REACTION TIME TEST; CRITICAL FLICKER FUSION; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; FEMALE; GALACTOSE ELIMINATION CAPACITY; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER DISEASE; LIVER FUNCTION TEST; LIVER METABOLISM; MAJOR CLINICAL STUDY; MALE; MINIMAL HEPATIC ENCEPHALOPATHY; POINT OF CARE TESTING; RESPONSE TIME; STIMULUS RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; AMMONIA; FEMALE; FLICKER FUSION; HEPATIC ENCEPHALOPATHY; HUMANS; MALE; MIDDLE AGED; PSYCHOMETRICS; REACTION TIME; STATISTICAL DISTRIBUTIONS;

EID: 79959379820     PISSN: 08857490     EISSN: 15737365     Source Type: Journal    
DOI: 10.1007/s11011-011-9242-1     Document Type: Article

References (29)

1. P Amodio JC Quero F Del Piccolo A Gatta SW Schalm 1996 Diagnostic tools for the detection of subclinical hepatic encephalopathy: comparison of standard and computerized psychometric tests with spectral-eeg Metab Brain Dis 11 315 327 8979251 10.1007/BF02029493 1:STN:280:DyaK2s7jtlymtA%3D%3D (Pubitemid 27004857)
2. P Amodio S Montagnese A Gatta MY Morgan 2004 Characteristics of minimal hepatic encephalopathy Metab Brain Dis 19 253 267 15554421 10.1023/B:MEBR. 0000043975.01841.de (Pubitemid 39361187)
3. JS Bajaj 2008 Minimal hepatic encephalopathy matters in daily life World J Gastroenterol 14 3609 3615 18595126 10.3748/wjg.14.3609
4. ZJ Bao DK Qiu X Ma, et al. 2007 Assessment of health-related quality of life in chinese patients with minimal hepatic encephalopathy World J Gastroenterol 13 3003 3008 17589955 (Pubitemid 47028892)
5. RK Dhiman VA Saraswat BK Sharma, et al. 2010 Minimal hepatic encephalopathy: consensus statement of a working party of the indian national association for study of the liver J Gastroenterol Hepatol 25 1029 1041 10.1111/j.1440-1746.2010.06318.x 20594216 10.1111/j.1440-1746.2010.06318.x
6. P Elsass SE Christensen L Ranek A Theilgaard N Tygstrup 1981 Continuous reaction time in patients with hepatic encephalopathy. A quantitative measure of changes in consciousness Scand J Gastroenterol 16 441 447 16435490 10.3109/00365528109181995 1:STN:280:DC%2BD28%2FkvFGrtA%3D%3D (Pubitemid 11113617)
7. P Ferenci A Lockwood K Mullen R Tarter K Weissenborn AT Blei 2002 Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th world congresses of gastroenterology, vienna, 1998 Hepatology 35 716 721 10.1053/jhep.2002.31250 11870389 10.1053/jhep.2002.31250 (Pubitemid 34183979)
8. M Groeneweg JC Quero I De Bruijn, et al. 1998 Subclinical hepatic encephalopathy impairs daily functioning Hepatology 28 45 49 10.1002/hep.510280108 9657095 10.1002/hep.510280108 1:STN:280: DyaK1czhvFWktQ%3D%3D (Pubitemid 28299984)
9. M Groeneweg W Moerland JC Quero WC Hop PF Krabbe SW Schalm 2000 Screening of subclinical hepatic encephalopathy J Hepatol 32 748 753 10845661 10.1016/S0168-8278(00)80243-3 1:STN:280:DC%2BD3cvnt12guw%3D%3D (Pubitemid 30262734)
10. D Haussinger F Schliess G Kircheis 2002 Pathogenesis of hepatic encephalopathy J Gastroenterol Hepatol 17 Suppl 3 S256 S259 12472946 10.1046/j.1440-1746.17.s3.10.x (Pubitemid 35454294)
11. Jakobsen LH, Sorensen JM, Rask IK, Jensen BS, Kondrup J (2010) Validation of reaction time as a measure of cognitive function and quality of life in healthy subjects and patients. Nutrition.doi: 10.1016/j.nut.2010.08.003
12. POP Jepsen PK Andersen HT Sørensen H Vilstrup 2010 The clinical course of alcoholic cirrhosis with ascites: effects of liver and kidney function, hyponatremia, and alcohol Hepatology 52 896A 10.1002/hep.24019
13. G Kircheis M Wettstein L Timmermann A Schnitzler D Haussinger 2002 Critical flicker frequency for quantification of low-grade hepatic encephalopathy Hepatology 35 357 366 10.1053/jhep.2002.30957 11826409 10.1053/jhep.2002.30957 (Pubitemid 34106375)
14. G Kircheis JG Bode N Hilger T Kramer A Schnitzler D Haussinger 2009 Diagnostic and prognostic values of critical flicker frequency determination as new diagnostic tool for objective he evaluation in patients undergoing tips implantation Eur J Gastroenterol Hepatol 21 1383 1394 10.1097/MEG. 0b013e328310e0c3 19738480 10.1097/MEG.0b013e328310e0c3
15. G Kircheis A Knoche N Hilger, et al. 2009 Hepatic encephalopathy and fitness to drive Gastroenterology 137 1706 1715 10.1053/j.gastro.2009.08.003 19686744 10.1053/j.gastro.2009.08.003
16. YY Li YQ Nie WH Sha, et al. 2004 Prevalence of subclinical hepatic encephalopathy in cirrhotic patients in China World J Gastroenterol 10 2397 2401 15285027
17. S Montagnese P Amodio MY Morgan 2004 Methods for diagnosing hepatic encephalopathy in patients with cirrhosis: a multidimensional approach Metab Brain Dis 19 281 312 15554423 10.1023/B:MEBR.0000043977.11113.2a (Pubitemid 39361189)
18. M Ortiz C Jacas J Cordoba 2005 Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations J Hepatol 42 Suppl S45 S53 10.1016/j.jhep.2004.11.028 15777572 10.1016/j.jhep.2004.11.028 (Pubitemid 40364603)
19. S Prasad RK Dhiman A Duseja YK Chawla A Sharma R Agarwal 2007 Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy Hepatology 45 549 559 10.1002/hep.21533 17326150 10.1002/hep.21533 (Pubitemid 46450607)
20. C Randolph R Hilsabeck A Kato, et al. 2009 Neuropsychological assessment of hepatic encephalopathy: ishen practice guidelines Liver Int 29 629 635 10.1111/j.1478-3231.2009.02009.x 19302444 10.1111/j.1478-3231.2009.02009.x
21. GS Roback LR Krasno AC Ivy 1952 Effect of analeptic drugs on the somnifacient effect of seconal and antihistaminics as measured by the flicker fusion threshold J Appl Physiol 4 566 574 14907573 1:CAS:528: DyaG38XitFamuw%3D%3D
22. M Romero-Gomez 2010 Pharmacotherapy of hepatic encephalopathy in cirrhosis Expert Opin Pharmacother 11 1317 1327 10.1517/14656561003724721 20384539 10.1517/14656561003724721 1:CAS:528:DC%2BC3cXlslCisr4%3D
23. H Schomerus W Hamster 2001 Quality of life in cirrhotics with minimal hepatic encephalopathy Metab Brain Dis 16 37 41 11726087 10.1023/A:1011610427843 1:STN:280:DC%2BD3MnnvF2nuw%3D%3D (Pubitemid 33064035)
24. P Sharma BC Sharma 2010 Predictors of minimal hepatic encephalopathy in patients with cirrhosis Saudi J Gastroenterol 16 181 187 10.4103/1319-3767.65189 20616413 10.4103/1319-3767.65189
25. S Shukla A Shukla S Mehboob S Guha 2011 Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy Aliment Pharmacol Ther 10.1111/j.1365-2036.2010.04574.x 21251030
26. P Sjogren AK Olsen AB Thomsen J Dalberg 2000 Neuropsychological performance in cancer patients: the role of oral opioids, pain and performance status Pain 86 237 245 10812253 10.1016/S0304-3959(00)00248-7 1:CAS:528:DC%2BD3cXjt1ejt7s%3D (Pubitemid 30254264)
27. P Sjogren AB Thomsen AK Olsen 2000 Impaired neuropsychological performance in chronic nonmalignant pain patients receiving long-term oral opioid therapy J Pain Symptom Manage 19 100 108 10699537 10.1016/S0885-3924(99) 00143-8 1:STN:280:DC%2BD3c7msVOlug%3D%3D (Pubitemid 30116799)
28. JM Smith H Misiak 1976 Critical flicker frequency (cff) and psychotropic drugs in normal human subjects-a review Psychopharmacologia 47 175 182 1273214 10.1007/BF00735818 1:STN:280:DyaE287pvVaitA%3D%3D
29. N Tygstrup 1964 The galactose elimination capacity in control subjects and in patients with cirrhosis of the liver Acta Med Scand 175 281 289 14136243 10.1111/j.0954-6820.1964.tb00576.x 1:CAS:528:DyaF2cXksFKrsbY%3D